Form 4 for BEAM Beam Therapeutics Inc.
Accepted 2025-02-19 00:00:00 ET · period of report 2025-02-14 · accession 0000950170-25-023166 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-02-19 | 2025-02-14 | BEAM | Bellon Christine | CLO | S - Sale+OE | $34.00 | -10.0K | 103.0K | -9% | -$340.0K |
| DMT | 2025-02-19 | 2025-02-14 | BEAM | Bellon Christine | CLO | M - OptEx | $7.22 | +10.0K | 112.5K | +10% | +$72.2K |
| DMT | 2025-02-19 | 2025-02-14 | BEAM | Bellon Christine | CLO | M - OptEx | $0.00 | -10.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-14 | S | D | 10,000 | $34.00 | 102,968 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-14 | M | A | 508 | $7.22 | 112,968 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-14 | M | A | 9,492 | $7.22 | 112,460 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2025-02-14 | M | D | 508 | $0.00 | 10,410 | D | $7.22 · — to 2029-05-17 | 508 Common Stock | (F3) The option vested as to 25% on the first anniversary of the vesting commencement date, May 17, 2020, and at a rate of 2.78% each month thereafter until the option was fully vested. |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-02-14 | M | D | 9,492 | $0.00 | 0 | D | $7.22 · — to 2029-05-16 | 9,492 Common Stock | (F2) The option vested as to 25% on the first anniversary of the vesting commencement date, May 16, 2020, and at a rate of 2.78% each month thereafter until the option was fully vested. |